GHP Q1 2022

2 GHP / Q1 2022 Contents , Welcome to the Q1 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape. With tensions continuing to build around the globe, we can see an influx of individuals and businesses that promote togetherness. Here we can see the building blocks to a better future in health and research to overcome some of life’s greatest challenges. It is this togetherness that ensures safe spaces for people everywhere – mentally, physically, and emotionally. We experience these medical developments in a way that changes our perception of good health as well as our relationships with our bodies. In this issue we see the present and future of testing, holistic wellness, luxury training facilities, nutritional ingredient solutions, andmuchmore. With skilled and revolutionary clinics that are leaders in their industry; we open, continue, and finish strong throughout this entire issue. These excellent success stories show us more beneficial treatments and health services than ever before. We have been in touch with many companies, across an assortment of sectors, that are researching and enforcing new ways of curing, testing, and supporting people all over the world. For example, The Whiteley Clinic’s treatments in the field of phlebology has propelled it to a point of great success. With its blood research abilities and passion, it has been changing the course of healthcare. As spring swiftly approaches us, we at GHPwish you a very happyMarch. We look forward to seeing you again for Q2. Sofi Bajor, Editor Website: AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining frommaking any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.